Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating activities:
Net income (loss)	$ (14,096)	$ 8,151
Adjustments to reconcile net income to cash (used for) provided by operating activities:
Depreciation and amortization	28,720	17,911
Share-based compensation expense	4,505	3,035
Provision for losses on accounts receivable	3,619	1,073
Deferred income tax benefit	(8,613)	(1,482)
Changes in operating assets and liabilities:
Accounts receivable	(22,573)	(18,519)
Merchandise inventories	80,194	(30,556)
Accounts payable	(120,480)	9,478
Net change in other assets and liabilities	(15,858)	28,904
Other, net	3,678	278
Cash (used for) provided by operating activities	(60,904)	18,273
Investing activities:
Additions to property and equipment	(11,674)	(7,074)
Additions to computer software and intangible assets	(2,605)	(7,086)
Proceeds from sale of property and equipment	271	0
Cash used for investing activities	(14,008)	(14,160)
Financing activities:
Borrowings (repayments) under revolving credit facility	72,100	(300)
Repayments of debt	(12,394)	(3,125)
Financing costs paid	(4,313)	0
Cash dividends paid	(4,764)	(16,074)
Other, net	(1,124)	(2,304)
Cash provided by (used for) financing activities	49,505	(21,803)
Effect of exchange rate changes on cash and cash equivalents	(2,721)	800
Net decrease in cash and cash equivalents	(28,128)	(16,890)
Cash and cash equivalents at beginning of period	103,367	104,522
Cash and cash equivalents at end of period	75,239	87,632
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	(12,388)	1,197
Interest paid	$ 24,504	$ 9,661